Wednesday 4 April 2018

• 13:00 - 2nd Annual EURACAN Conference in collaboration with EIT Health "Innovation in Rare Cancer Management"
  Prof Jean-Yves Blay (Co-ordinator of ERN EURACAN and Professor of Oncology, Centre Léon Bérard), Prof Bass Hassan (UK& Ireland EIT health Chair and Professor of Medical Oncology, EIT health and Oxford University), Dr Hans Hofstraat (Vice President, Philips), Leila Luhesi (Associate Director, Oxford Nanopore Technologies), Prof David Capper (Charite Berlin), Dr Sandrine Marreaud (Head of Medical and Pharmacovigilance Department, EORTC), Dr Apostolos Tsiachristas (Senior Researcher in Health Economics, University of Oxford), Jane Lyons (CEO, Cancer52), Prof Pancras Hogendoorn (Professor of Pathology, Leiden University Medical Centre), Prof Ernst Hafen ( Project Leader, MiDATA), Phil Matthews (Health Cloud UK Product Manager, GE Healthcare), Dr Kevin Bradley (Consultant in Radiology and Nuclear Medicine, Oxford University Hospitals), David Cole (Innovation Lead Europe, IBM Watson)